NCT06629779 2026-04-16A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.PfizerPhase 3 Recruiting900 enrolled
NCT06318273 2026-04-08A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate CancerAbbViePhase 1 Recruiting230 enrolled